{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T18:55:51Z","timestamp":1762541751099},"reference-count":15,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T00:00:00Z","timestamp":1225497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2008,11]]},"DOI":"10.1016\/j.clinthera.2008.10.021","type":"journal-article","created":{"date-parts":[[2008,12,25]],"date-time":"2008-12-25T05:20:57Z","timestamp":1230182457000},"page":"2069-2074","source":"Crossref","is-referenced-by-count":35,"title":["Adverse drug reactions to treatments for ocular toxoplasmosis: A retrospective chart review"],"prefix":"10.1016","volume":"30","author":[{"given":"Barbara","family":"Iaccheri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tito","family":"Fiore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thekla","family":"Papadaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sofia","family":"Androudi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarosh","family":"Janjua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Imran","family":"Bhaila","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Stephen Foster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2008.10.021_bib1","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1097\/ICU.0b013e32801094ca","article-title":"Toxoplasmosis","volume":"17","author":"Dodds","year":"2006","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.clinthera.2008.10.021_bib2","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0002-9394(14)74456-3","article-title":"Therapy for ocular toxoplasmosis","volume":"115","author":"Rothova","year":"1993","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.clinthera.2008.10.021_bib3","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S0002-9394(02)01537-4","article-title":"A prospective, randomized trial of pyrimethamine and azithromycin vs pyrimethamine and sulfadiazine for the treatment of ocular toxoplasmosis","volume":"134","author":"Bosch-Driessen","year":"2002","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.clinthera.2008.10.021_bib4","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1093\/infdis\/171.5.1295","article-title":"Adverse events associated with trimethoprim-sulfamethoxazole and atovaquone during the treatment of AIDS-related Pneumocystis carinii pneumonia","volume":"171","author":"Hughes","year":"1995","journal-title":"J Infect Dis"},{"key":"10.1016\/j.clinthera.2008.10.021_bib5","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0161-6420(85)34001-0","article-title":"Standardization of vitreal inflammatory activity in intermediate and posterior uveitis","volume":"92","author":"Nussenblatt","year":"1985","journal-title":"Ophthalmology"},{"key":"10.1016\/j.clinthera.2008.10.021_bib6","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1001\/archopht.1960.01840010142016","article-title":"The hematologic toxicity of pyrimethamine (daraprim) in man","volume":"64","author":"Kaufman","year":"1960","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.clinthera.2008.10.021_bib7","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/0002-9394(64)91378-9","article-title":"The treatment of toxoplasma uveitis","volume":"58","author":"Giles","year":"1964","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.clinthera.2008.10.021_bib8","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S1081-1206(10)62718-4","article-title":"Clindamycin hypersensitivity appears to be rare","volume":"82","author":"Mazur","year":"1999","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"Suppl","key":"10.1016\/j.clinthera.2008.10.021_bib9","doi-asserted-by":"crossref","first-page":"S120","DOI":"10.1093\/infdis\/135.Supplement.S120","article-title":"Incidence of diarrhea and colitis associated with clindamycin therapy","volume":"135","author":"Neu","year":"1977","journal-title":"J Infect Dis"},{"key":"10.1016\/j.clinthera.2008.10.021_bib10","series-title":"Goodman and Gilman's The Pharmacological Basis of Therapeutics","first-page":"1135","article-title":"Antibicromial agents: Clindamycin","author":"Sande","year":"1990"},{"key":"10.1016\/j.clinthera.2008.10.021_bib11","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0924-8579(00)00293-4","article-title":"Treatment and prevention of antibiotic associated diarrhea","volume":"16","author":"Bergogne-B\u00e9r\u00e9zin","year":"2000","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.clinthera.2008.10.021_bib12","doi-asserted-by":"crossref","first-page":"179","DOI":"10.7326\/0003-4819-105-2-179","article-title":"Differences in metabolism of sulfonamides predisposing to idiosyncratic toxicity","volume":"105","author":"Shear","year":"1986","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clinthera.2008.10.021_bib13","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1136\/bjo.85.10.1260e","article-title":"Crystalluria with sulphadiazine","volume":"85","author":"Smith","year":"2001","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.clinthera.2008.10.021_bib14","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/S0002-9378(99)70224-3","article-title":"Treatment of toxoplasmosis during pregnancy: A multicenter study of impact on fetal transmission and children's sequelae at age 1 year","volume":"180","author":"Foulon","year":"1999","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.clinthera.2008.10.021_bib15","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S0161-6420(99)90021-0","article-title":"Atovaquone for the treatment of toxoplasma retinochoroiditis in immunocompetent patients","volume":"106","author":"Pearson","year":"1999","journal-title":"Ophthalmology"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291808003421?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291808003421?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,23]],"date-time":"2018-12-23T05:59:33Z","timestamp":1545544773000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291808003421"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11]]},"references-count":15,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2008,11]]}},"alternative-id":["S0149291808003421"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2008.10.021","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2008,11]]}}}